TREACE MEDICAL CONCEPTS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Treace Medical Concepts, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Treace Medical Concepts, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$15.4M, a 12.3% increase year-over-year.
  • Treace Medical Concepts, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$61.5M, a 29.1% decline year-over-year.
  • Treace Medical Concepts, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$49.5M, a 15.7% decline from 2022.
  • Treace Medical Concepts, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$42.8M, a 108% decline from 2021.
  • Treace Medical Concepts, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$20.6M, a 460% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$61.5M -$15.4M +$2.16M +12.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$63.7M -$21.2M -$8.94M -72.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-05
Q1 2024 -$54.7M -$18.7M -$5.22M -38.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-05
Q4 2023 -$49.5M -$6.28M -$1.87M -42.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$47.7M -$17.5M -$5.39M -44.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$42.3M -$12.3M +$4.96M +28.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-05
Q1 2023 -$47.2M -$13.5M -$4.42M -48.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-05
Q4 2022 -$42.8M -$4.41M +$2.21M +33.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$45M -$12.1M -$5.72M -89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$39.3M -$17.2M -$12.2M -239% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$27.2M -$9.04M -$6.6M -272% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$20.6M -$6.62M -$9.19M -358% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$11.4M -$6.42M -$3.76M -142% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$7.6M -$5.08M -$3.11M -158% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$4.49M -$2.43M -$825K -51.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$3.67M $2.57M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-08
Q3 2020 -$2.66M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$1.97M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$1.61M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.